CA3023821A1 - Skin freezing systems for treating acne and skin conditions - Google Patents
Skin freezing systems for treating acne and skin conditions Download PDFInfo
- Publication number
- CA3023821A1 CA3023821A1 CA3023821A CA3023821A CA3023821A1 CA 3023821 A1 CA3023821 A1 CA 3023821A1 CA 3023821 A CA3023821 A CA 3023821A CA 3023821 A CA3023821 A CA 3023821A CA 3023821 A1 CA3023821 A1 CA 3023821A1
- Authority
- CA
- Canada
- Prior art keywords
- skin
- temperature
- applicator
- freezing
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000007710 freezing Methods 0.000 title claims description 358
- 230000008014 freezing Effects 0.000 title claims description 357
- 206010000496 acne Diseases 0.000 title claims description 34
- 208000002874 Acne Vulgaris Diseases 0.000 title claims description 28
- 238000000034 method Methods 0.000 claims abstract description 301
- 238000001816 cooling Methods 0.000 claims abstract description 193
- 239000013078 crystal Substances 0.000 claims abstract description 115
- 239000000126 substance Substances 0.000 claims abstract description 112
- 230000006911 nucleation Effects 0.000 claims abstract description 43
- 238000010899 nucleation Methods 0.000 claims abstract description 43
- 210000003491 skin Anatomy 0.000 claims description 652
- 210000001519 tissue Anatomy 0.000 claims description 422
- 238000011282 treatment Methods 0.000 claims description 274
- 230000008878 coupling Effects 0.000 claims description 259
- 238000010168 coupling process Methods 0.000 claims description 259
- 238000005859 coupling reaction Methods 0.000 claims description 259
- 239000000017 hydrogel Substances 0.000 claims description 165
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 126
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 123
- 238000004781 supercooling Methods 0.000 claims description 97
- 210000002615 epidermis Anatomy 0.000 claims description 93
- 230000006378 damage Effects 0.000 claims description 63
- 230000002500 effect on skin Effects 0.000 claims description 59
- 210000004027 cell Anatomy 0.000 claims description 57
- 239000002577 cryoprotective agent Substances 0.000 claims description 53
- 210000004207 dermis Anatomy 0.000 claims description 47
- 239000002502 liposome Substances 0.000 claims description 44
- 239000012530 fluid Substances 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 35
- 230000000994 depressogenic effect Effects 0.000 claims description 31
- 238000002604 ultrasonography Methods 0.000 claims description 30
- 230000006910 ice nucleation Effects 0.000 claims description 29
- 239000002667 nucleating agent Substances 0.000 claims description 29
- 239000000839 emulsion Substances 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 26
- 210000001732 sebaceous gland Anatomy 0.000 claims description 26
- 208000027418 Wounds and injury Diseases 0.000 claims description 25
- 230000001965 increasing effect Effects 0.000 claims description 25
- 230000000977 initiatory effect Effects 0.000 claims description 25
- 208000014674 injury Diseases 0.000 claims description 25
- 238000010792 warming Methods 0.000 claims description 23
- 230000015572 biosynthetic process Effects 0.000 claims description 20
- 230000008859 change Effects 0.000 claims description 17
- 230000002401 inhibitory effect Effects 0.000 claims description 16
- 230000035699 permeability Effects 0.000 claims description 16
- 238000010521 absorption reaction Methods 0.000 claims description 13
- 238000010257 thawing Methods 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000000853 adhesive Substances 0.000 claims description 12
- 230000001070 adhesive effect Effects 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 12
- 230000001225 therapeutic effect Effects 0.000 claims description 12
- 239000000499 gel Substances 0.000 claims description 11
- 239000000523 sample Substances 0.000 claims description 10
- 210000000434 stratum corneum Anatomy 0.000 claims description 9
- 238000007865 diluting Methods 0.000 claims description 8
- 150000002632 lipids Chemical class 0.000 claims description 8
- 230000036961 partial effect Effects 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 230000001680 brushing effect Effects 0.000 claims description 7
- 229920006037 cross link polymer Polymers 0.000 claims description 7
- 238000000315 cryotherapy Methods 0.000 claims description 7
- 239000007908 nanoemulsion Substances 0.000 claims description 7
- 239000004971 Cross linker Substances 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 238000012544 monitoring process Methods 0.000 claims description 6
- 239000007764 o/w emulsion Substances 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 239000007762 w/o emulsion Substances 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 241000588698 Erwinia Species 0.000 claims description 4
- 241000589516 Pseudomonas Species 0.000 claims description 4
- 241000589634 Xanthomonas Species 0.000 claims description 4
- 230000036760 body temperature Effects 0.000 claims description 4
- 230000001351 cycling effect Effects 0.000 claims description 4
- 230000000035 biogenic effect Effects 0.000 claims description 3
- 230000000254 damaging effect Effects 0.000 claims description 3
- 238000005538 encapsulation Methods 0.000 claims description 3
- 238000004299 exfoliation Methods 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 2
- 210000001339 epidermal cell Anatomy 0.000 claims description 2
- 230000004936 stimulating effect Effects 0.000 claims 2
- 230000037368 penetrate the skin Effects 0.000 claims 1
- 230000037384 skin absorption Effects 0.000 claims 1
- 231100000274 skin absorption Toxicity 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 49
- 230000000694 effects Effects 0.000 abstract description 32
- 239000003999 initiator Substances 0.000 abstract description 17
- 239000010410 layer Substances 0.000 description 99
- 238000002844 melting Methods 0.000 description 50
- 230000008018 melting Effects 0.000 description 50
- 239000003795 chemical substances by application Substances 0.000 description 41
- 238000007920 subcutaneous administration Methods 0.000 description 35
- 206010033675 panniculitis Diseases 0.000 description 24
- 239000000203 mixture Substances 0.000 description 20
- 210000004304 subcutaneous tissue Anatomy 0.000 description 20
- 210000003780 hair follicle Anatomy 0.000 description 19
- 210000004907 gland Anatomy 0.000 description 18
- 239000011148 porous material Substances 0.000 description 16
- 230000004913 activation Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 210000000106 sweat gland Anatomy 0.000 description 15
- 208000008454 Hyperhidrosis Diseases 0.000 description 14
- 210000002374 sebum Anatomy 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 230000001960 triggered effect Effects 0.000 description 13
- 239000002826 coolant Substances 0.000 description 12
- 239000007822 coupling agent Substances 0.000 description 12
- 238000011081 inoculation Methods 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 230000037315 hyperhidrosis Effects 0.000 description 11
- 230000003834 intracellular effect Effects 0.000 description 11
- 230000007423 decrease Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 210000000577 adipose tissue Anatomy 0.000 description 9
- 230000000670 limiting effect Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000000451 tissue damage Effects 0.000 description 9
- 231100000827 tissue damage Toxicity 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 230000037303 wrinkles Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 210000003499 exocrine gland Anatomy 0.000 description 7
- 230000004907 flux Effects 0.000 description 7
- 230000004927 fusion Effects 0.000 description 7
- 210000005036 nerve Anatomy 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- -1 cryoprobes Substances 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 238000012261 overproduction Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 210000004243 sweat Anatomy 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 230000002411 adverse Effects 0.000 description 5
- 238000013019 agitation Methods 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 210000004209 hair Anatomy 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 231100000518 lethal Toxicity 0.000 description 5
- 230000001665 lethal effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 210000004003 subcutaneous fat Anatomy 0.000 description 5
- 208000003367 Hypopigmentation Diseases 0.000 description 4
- 241000589615 Pseudomonas syringae Species 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 230000009746 freeze damage Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 208000000069 hyperpigmentation Diseases 0.000 description 4
- 230000003810 hyperpigmentation Effects 0.000 description 4
- 230000003425 hypopigmentation Effects 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229920001451 polypropylene glycol Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000001902 propagating effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 3
- 206010054107 Nodule Diseases 0.000 description 3
- 206010033733 Papule Diseases 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 206010037888 Rash pustular Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000009189 diving Effects 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 210000001723 extracellular space Anatomy 0.000 description 3
- 230000004761 fibrosis Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 208000002557 hidradenitis Diseases 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000004968 inflammatory condition Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 208000029561 pustule Diseases 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 230000037390 scarring Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 208000037816 tissue injury Diseases 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 208000035484 Cellulite Diseases 0.000 description 2
- 241001635598 Enicostema Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 206010027626 Milia Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010049752 Peau d'orange Diseases 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 206010047141 Vasodilatation Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000001099 axilla Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000036232 cellulite Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000008393 encapsulating agent Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 108010063679 ice nucleation protein Proteins 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003860 topical agent Substances 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 241000837181 Andina Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000010305 Epidermal Cyst Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000006787 Port-Wine Stain Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 206010048810 Sebaceous hyperplasia Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 238000002681 cryosurgery Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 210000001703 glandular epithelial cell Anatomy 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 239000013529 heat transfer fluid Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000012802 pre-warming Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011268 retreatment Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 201000005218 sebaceous adenoma Diseases 0.000 description 1
- 210000004378 sebocyte Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0052—Body part for treatment of skin or hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
- A61F2007/0056—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
- A61F2007/0075—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating using a Peltier element, e.g. near the spot to be heated or cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0086—Heating or cooling appliances for medical or therapeutic treatment of the human body with a thermostat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0087—Hand-held applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0093—Heating or cooling appliances for medical or therapeutic treatment of the human body programmed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0095—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
- A61F2007/0096—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator with a thermometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0203—Cataplasms, poultices or compresses, characterised by their contents; Bags therefor
- A61F2007/0215—Cataplasms, poultices or compresses, characterised by their contents; Bags therefor containing liquids other than water
- A61F2007/0219—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
- A61F2007/108—Cold packs, i.e. devices to be cooled or frozen in refrigerator or freezing compartment
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Surgical Instruments (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662334330P | 2016-05-10 | 2016-05-10 | |
| US201662334317P | 2016-05-10 | 2016-05-10 | |
| US201662334213P | 2016-05-10 | 2016-05-10 | |
| US201662334337P | 2016-05-10 | 2016-05-10 | |
| US62/334,330 | 2016-05-10 | ||
| US62/334,337 | 2016-05-10 | ||
| US62/334,213 | 2016-05-10 | ||
| US62/334,317 | 2016-05-10 | ||
| PCT/US2017/029887 WO2017196548A1 (en) | 2016-05-10 | 2017-04-27 | Skin freezing systems for treating acne and skin conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3023821A1 true CA3023821A1 (en) | 2017-11-16 |
Family
ID=58692637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3023821A Abandoned CA3023821A1 (en) | 2016-05-10 | 2017-04-27 | Skin freezing systems for treating acne and skin conditions |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3454800A1 (enExample) |
| JP (1) | JP2019514616A (enExample) |
| KR (1) | KR20190005981A (enExample) |
| CN (1) | CN109310516A (enExample) |
| AU (1) | AU2017264512A1 (enExample) |
| BR (1) | BR112018073275A2 (enExample) |
| CA (1) | CA3023821A1 (enExample) |
| WO (1) | WO2017196548A1 (enExample) |
Cited By (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10471269B1 (en) | 2015-07-01 | 2019-11-12 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10478633B2 (en) | 2015-07-01 | 2019-11-19 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10596386B2 (en) | 2016-07-01 | 2020-03-24 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10632321B2 (en) | 2016-07-01 | 2020-04-28 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10695575B1 (en) | 2016-05-10 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10695576B2 (en) | 2015-07-01 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10709895B2 (en) | 2016-05-10 | 2020-07-14 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10709894B2 (en) | 2015-07-01 | 2020-07-14 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10821295B1 (en) | 2015-07-01 | 2020-11-03 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US11185690B2 (en) | 2016-05-23 | 2021-11-30 | BTL Healthcare Technologies, a.s. | Systems and methods for tissue treatment |
| US11247063B2 (en) | 2019-04-11 | 2022-02-15 | Btl Healthcare Technologies A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11253718B2 (en) | 2015-07-01 | 2022-02-22 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
| US11491329B2 (en) | 2020-05-04 | 2022-11-08 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11612758B2 (en) | 2012-07-05 | 2023-03-28 | Btl Medical Solutions A.S. | Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields |
| US11633596B2 (en) | 2020-05-04 | 2023-04-25 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12064163B2 (en) | 2021-10-13 | 2024-08-20 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12156689B2 (en) | 2019-04-11 | 2024-12-03 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12274494B2 (en) | 2016-08-16 | 2025-04-15 | Btl Healthcare Technologies A.S. | Treatment device |
| US12369965B2 (en) | 2021-12-30 | 2025-07-29 | Cryosa, Inc. | Systems and methods for treatment of obstructive sleep apnea |
| US12514748B2 (en) | 2011-01-27 | 2026-01-06 | Cryosa, Inc. | Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues |
| US12551259B2 (en) | 2020-02-19 | 2026-02-17 | Cryosa, Inc. | Systems and methods for treatment of obstructive sleep apnea |
| US12558146B2 (en) | 2019-04-11 | 2026-02-24 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12558257B2 (en) | 2018-12-31 | 2026-02-24 | Cryosa, Inc. | Systems and methods for treatment of obstructive sleep apnea |
| US12564726B1 (en) | 2024-10-08 | 2026-03-03 | Btl Medical Solutions A.S. | Devices and methods for application of a magnetic field to the nervous system |
| US12611545B2 (en) | 2020-05-04 | 2026-04-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12654023B2 (en) | 2016-05-10 | 2026-06-16 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3463132B1 (en) * | 2016-06-03 | 2024-07-24 | R2 Technologies, Inc. | Cooling systems for skin treatment |
| US11477981B2 (en) | 2016-06-29 | 2022-10-25 | The General Hospital Corporation | Ice nucleation formulations for cryopreservation and stabilization of biologics |
| WO2018085212A1 (en) | 2016-11-02 | 2018-05-11 | Velis Christopher J P | Devices and methods for slurry generation |
| US11324673B2 (en) | 2016-11-18 | 2022-05-10 | Miraki Innovation Think Tank Llc | Cosmetic appearance of skin |
| EP3606482A4 (en) | 2017-04-05 | 2021-01-06 | Miraki Innovation Think Tank LLC | PRODUCTION OF A COLD THICK SUSPENSION AT THE POINT OF ADMINISTRATION |
| EP3606456A4 (en) | 2017-04-05 | 2021-01-13 | Miraki Innovation Think Tank LLC | COLD THICK SUSPENSION CONTAINMENT |
| US10500342B2 (en) | 2017-08-21 | 2019-12-10 | Miraki Innovation Think Tank Llc | Cold slurry syringe |
| KR102651464B1 (ko) * | 2018-03-30 | 2024-03-26 | 주식회사 리센스메디컬 | 착탈식 냉각 매체 및 이를 이용한 냉각 방법 |
| CN108836619A (zh) * | 2018-07-17 | 2018-11-20 | 北京麦邦光电仪器有限公司 | 目标温度治疗探头、治疗钳及目标温度治疗装置 |
| CN112955099B (zh) | 2018-07-27 | 2024-04-26 | 雷森斯医疗有限公司 | 医疗冷却装置和使用其的冷却方法 |
| US20210338568A1 (en) * | 2018-08-31 | 2021-11-04 | Shiseido Company, Ltd. | Cosmetic method |
| EP3747467A3 (en) * | 2019-06-03 | 2021-03-03 | Nanobacterie | A cryosystem comprising nanoparticles for treating a body part of an individual by cryotherapy |
| CN114431947A (zh) * | 2020-10-30 | 2022-05-06 | 上海微创惟美医疗科技(集团)有限公司 | 冷冻减脂装置及可读存储介质 |
| WO2022159515A1 (en) | 2021-01-20 | 2022-07-28 | R2 Technologies, Inc. | Dermatological treatments and systems employing cooling, topicals, and/or abrasion |
| CN115220488B (zh) * | 2022-06-28 | 2023-11-21 | 广东花至美容科技有限公司 | 仿生皮肤温度的控制方法和装置 |
| CN120789497B (zh) * | 2025-07-24 | 2026-07-14 | 深圳由莱智能电子有限公司 | 美容仪的控制方法和美容仪 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998041156A1 (en) | 1997-03-17 | 1998-09-24 | Boris Rubinsky | The use of cryoprotective agent compounds during cryosurgery |
| AU6561898A (en) | 1997-03-17 | 1998-10-12 | Boris Rubinsky | Freezing method for controlled removal of fatty tissue by liposuction |
| US6887260B1 (en) * | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| CN1520276A (zh) * | 2001-06-27 | 2004-08-11 | 痤疮治疗 | |
| US8840608B2 (en) | 2002-03-15 | 2014-09-23 | The General Hospital Corporation | Methods and devices for selective disruption of fatty tissue by controlled cooling |
| CN102018591A (zh) | 2002-03-15 | 2011-04-20 | 总医院公司 | 通过受控冷却对脂肪组织进行选择性破坏的方法和装置 |
| CA2516122C (en) * | 2003-01-15 | 2016-07-26 | Cryodynamics, Llc | Cryotherapy probe and system |
| US20050281789A1 (en) * | 2004-05-20 | 2005-12-22 | Mangala Rao | Transcutaneous and/or transdermal transport of materials |
| US7854754B2 (en) | 2006-02-22 | 2010-12-21 | Zeltiq Aesthetics, Inc. | Cooling device for removing heat from subcutaneous lipid-rich cells |
| GB0605107D0 (en) * | 2006-03-14 | 2006-04-26 | Bioforskning As | Use |
| BRPI0706055B8 (pt) | 2006-04-28 | 2021-06-22 | Zeltiq Aesthetics Inc | sistema e conjunto de componentes para remover calor de células subcutâneas ricas em lipídios |
| DK2012707T3 (da) * | 2006-04-28 | 2020-05-18 | Zeltiq Aesthetics Inc | Kryobeskytter til brug med en behandlingsanordning til forbedret køling af subkutane, lipidrige celler |
| US20070270925A1 (en) | 2006-05-17 | 2007-11-22 | Juniper Medical, Inc. | Method and apparatus for non-invasively removing heat from subcutaneous lipid-rich cells including a coolant having a phase transition temperature |
| US20080077201A1 (en) | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Cooling devices with flexible sensors |
| US9132031B2 (en) | 2006-09-26 | 2015-09-15 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
| US8192474B2 (en) | 2006-09-26 | 2012-06-05 | Zeltiq Aesthetics, Inc. | Tissue treatment methods |
| JP2010508130A (ja) | 2006-10-31 | 2010-03-18 | ゼルティック エステティックス インコーポレイテッド | 皮下高脂質細胞または皮下高脂質組織を冷却する方法およびその装置 |
| US20080114348A1 (en) * | 2006-11-13 | 2008-05-15 | Vancelette David W | Cryoprotective Agent Delivery |
| US20080287839A1 (en) | 2007-05-18 | 2008-11-20 | Juniper Medical, Inc. | Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator |
| US20090018625A1 (en) | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Managing system temperature to remove heat from lipid-rich regions |
| US20090018626A1 (en) | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | User interfaces for a system that removes heat from lipid-rich regions |
| US20090018624A1 (en) | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Limiting use of disposable system patient protection devices |
| US8523927B2 (en) | 2007-07-13 | 2013-09-03 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
| US20090018627A1 (en) | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Secure systems for removing heat from lipid-rich regions |
| CN101917944B (zh) | 2007-08-21 | 2014-11-19 | 斯尔替克美学股份有限公司 | 监视诸如脂肪组织的冷却这种皮下富含脂质的细胞的冷却 |
| US20090111736A1 (en) * | 2007-10-29 | 2009-04-30 | Sri International | Orally-Absorbed Solid Dose Formulation for Vancomycin |
| EP3811912A1 (en) * | 2008-08-07 | 2021-04-28 | The General Hospital Corporation | Method and apparatus for dermatological hypopigmentation |
| WO2010036732A1 (en) | 2008-09-25 | 2010-04-01 | Zeltiq Aesthetics, Inc. | Treatment planning systems and methods for body contouring applications |
| US8603073B2 (en) | 2008-12-17 | 2013-12-10 | Zeltiq Aesthetics, Inc. | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
| KR101759116B1 (ko) | 2009-04-30 | 2017-07-18 | 젤티크 애스세틱스, 인코포레이티드. | 피하 지질 과다 세포로부터 열을 제거하는 디바이스, 시스템 및 방법 |
| US20110040361A1 (en) * | 2009-08-12 | 2011-02-17 | Elizabeth Joyce Levy | Cosmetic and Dermatological Cryotherapy Device |
| CN102791227A (zh) | 2010-01-25 | 2012-11-21 | 斯尔替克美学股份有限公司 | 用于通过相变冷却剂从皮下富脂细胞无创去除热量的家用施用器以及相关的装置、系统和方法 |
| US8676338B2 (en) | 2010-07-20 | 2014-03-18 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
| US10722395B2 (en) | 2011-01-25 | 2020-07-28 | Zeltiq Aesthetics, Inc. | Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells |
| CN109602489A (zh) * | 2011-11-16 | 2019-04-12 | 通用医疗公司 | 用于低温处理皮肤组织的方法和装置 |
| EP2779970B1 (en) * | 2011-11-16 | 2020-09-02 | The General Hospital Corporation | Method and apparatus for cryogenic treatment of skin tissue |
| EP2606845B1 (en) * | 2011-12-23 | 2016-10-26 | Lina Medical ApS | Pulse generator |
| US9844460B2 (en) | 2013-03-14 | 2017-12-19 | Zeltiq Aesthetics, Inc. | Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same |
| US9545523B2 (en) | 2013-03-14 | 2017-01-17 | Zeltiq Aesthetics, Inc. | Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue |
| KR101487850B1 (ko) * | 2013-08-08 | 2015-02-02 | (주)클래시스 | 냉각을 이용한 비만치료 장치 |
| US20170165105A1 (en) * | 2014-01-31 | 2017-06-15 | The General Hospital Corporation | Methods, kits, and cooling devices for disrupting function of one or more sebaceous glands |
| ES2974899T3 (es) | 2014-01-31 | 2024-07-02 | Zeltiq Aesthetics Inc | Composiciones y sistemas de tratamiento para el enfriamiento mejorado de tejido rico en lípidos |
| US20150223975A1 (en) * | 2014-02-12 | 2015-08-13 | The General Hospital Corporation | Method and apparatus for affecting pigmentation of tissue |
| US10935174B2 (en) | 2014-08-19 | 2021-03-02 | Zeltiq Aesthetics, Inc. | Stress relief couplings for cryotherapy apparatuses |
| US9752856B2 (en) | 2014-08-21 | 2017-09-05 | Michael Blake Rashad | Protective collapsible shield |
| US20160089550A1 (en) | 2014-09-25 | 2016-03-31 | Zeltiq Aesthetics, Inc. | Treatment systems, methods, and apparatuses for altering the appearance of skin |
| US20160317346A1 (en) | 2015-04-28 | 2016-11-03 | Zeltiq Aesthetics, Inc. | Systems and methods for monitoring cooling of skin and tissue to identify freeze events |
-
2017
- 2017-04-27 KR KR1020187035845A patent/KR20190005981A/ko not_active Ceased
- 2017-04-27 BR BR112018073275-3A patent/BR112018073275A2/pt not_active Application Discontinuation
- 2017-04-27 JP JP2018559772A patent/JP2019514616A/ja active Pending
- 2017-04-27 WO PCT/US2017/029887 patent/WO2017196548A1/en not_active Ceased
- 2017-04-27 AU AU2017264512A patent/AU2017264512A1/en not_active Abandoned
- 2017-04-27 CA CA3023821A patent/CA3023821A1/en not_active Abandoned
- 2017-04-27 CN CN201780038438.0A patent/CN109310516A/zh active Pending
- 2017-04-27 EP EP17722615.6A patent/EP3454800A1/en not_active Withdrawn
Cited By (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12514748B2 (en) | 2011-01-27 | 2026-01-06 | Cryosa, Inc. | Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues |
| US11612758B2 (en) | 2012-07-05 | 2023-03-28 | Btl Medical Solutions A.S. | Device for repetitive nerve stimulation in order to break down fat tissue means of inductive magnetic fields |
| US11253718B2 (en) | 2015-07-01 | 2022-02-22 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US10478633B2 (en) | 2015-07-01 | 2019-11-19 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US12691296B2 (en) | 2015-07-01 | 2026-07-28 | Btl Medical Solutions A.S. | High power time varying magnetic field therapy |
| US10471269B1 (en) | 2015-07-01 | 2019-11-12 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US11266850B2 (en) | 2015-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US10695576B2 (en) | 2015-07-01 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10709894B2 (en) | 2015-07-01 | 2020-07-14 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10821295B1 (en) | 2015-07-01 | 2020-11-03 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
| US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11602629B2 (en) | 2016-05-03 | 2023-03-14 | Btl Healthcare Technologies A.S. | Systems and methods for treatment of a patient including rf and electrical energy |
| US11883643B2 (en) | 2016-05-03 | 2024-01-30 | Btl Healthcare Technologies A.S. | Systems and methods for treatment of a patient including RF and electrical energy |
| US12521562B2 (en) | 2016-05-03 | 2026-01-13 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US12109426B2 (en) | 2016-05-10 | 2024-10-08 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11590356B2 (en) | 2016-05-10 | 2023-02-28 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12589256B2 (en) | 2016-05-10 | 2026-03-31 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12685873B2 (en) | 2016-05-10 | 2026-07-21 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12654023B2 (en) | 2016-05-10 | 2026-06-16 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12667733B2 (en) | 2016-05-10 | 2026-06-30 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12151120B2 (en) | 2016-05-10 | 2024-11-26 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11691024B2 (en) | 2016-05-10 | 2023-07-04 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11464994B2 (en) | 2016-05-10 | 2022-10-11 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US10695575B1 (en) | 2016-05-10 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10709895B2 (en) | 2016-05-10 | 2020-07-14 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US11896821B2 (en) | 2016-05-23 | 2024-02-13 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11623083B2 (en) | 2016-05-23 | 2023-04-11 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11185690B2 (en) | 2016-05-23 | 2021-11-30 | BTL Healthcare Technologies, a.s. | Systems and methods for tissue treatment |
| US11878162B2 (en) | 2016-05-23 | 2024-01-23 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11458307B2 (en) | 2016-05-23 | 2022-10-04 | Btl Healthcare Technologies A.S. | Systems and methods for tissue treatment |
| US11794029B2 (en) | 2016-07-01 | 2023-10-24 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12521565B2 (en) | 2016-07-01 | 2026-01-13 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11607556B2 (en) | 2016-07-01 | 2023-03-21 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11266852B2 (en) | 2016-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12623088B2 (en) | 2016-07-01 | 2026-05-12 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US10632321B2 (en) | 2016-07-01 | 2020-04-28 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10596386B2 (en) | 2016-07-01 | 2020-03-24 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US11497925B2 (en) | 2016-07-01 | 2022-11-15 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11628308B2 (en) | 2016-07-01 | 2023-04-18 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11679270B2 (en) | 2016-07-01 | 2023-06-20 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11524171B2 (en) | 2016-07-01 | 2022-12-13 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12109427B2 (en) | 2016-07-01 | 2024-10-08 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11484727B2 (en) | 2016-07-01 | 2022-11-01 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US12274494B2 (en) | 2016-08-16 | 2025-04-15 | Btl Healthcare Technologies A.S. | Treatment device |
| US12558257B2 (en) | 2018-12-31 | 2026-02-24 | Cryosa, Inc. | Systems and methods for treatment of obstructive sleep apnea |
| US12076576B2 (en) | 2019-04-11 | 2024-09-03 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12156689B2 (en) | 2019-04-11 | 2024-12-03 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12558146B2 (en) | 2019-04-11 | 2026-02-24 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11484725B2 (en) | 2019-04-11 | 2022-11-01 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11247063B2 (en) | 2019-04-11 | 2022-02-15 | Btl Healthcare Technologies A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12551259B2 (en) | 2020-02-19 | 2026-02-17 | Cryosa, Inc. | Systems and methods for treatment of obstructive sleep apnea |
| US12558542B2 (en) | 2020-05-04 | 2026-02-24 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11813451B2 (en) | 2020-05-04 | 2023-11-14 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11679255B2 (en) | 2020-05-04 | 2023-06-20 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11491329B2 (en) | 2020-05-04 | 2022-11-08 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11806528B2 (en) | 2020-05-04 | 2023-11-07 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12427307B2 (en) | 2020-05-04 | 2025-09-30 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12029905B2 (en) | 2020-05-04 | 2024-07-09 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12611545B2 (en) | 2020-05-04 | 2026-04-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12311170B2 (en) | 2020-05-04 | 2025-05-27 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11633596B2 (en) | 2020-05-04 | 2023-04-25 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US11826565B2 (en) | 2020-05-04 | 2023-11-28 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12064163B2 (en) | 2021-10-13 | 2024-08-20 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12702470B2 (en) | 2021-10-13 | 2026-08-11 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12678215B2 (en) | 2021-10-13 | 2026-07-14 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12115365B2 (en) | 2021-11-03 | 2024-10-15 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12369965B2 (en) | 2021-12-30 | 2025-07-29 | Cryosa, Inc. | Systems and methods for treatment of obstructive sleep apnea |
| US12484950B2 (en) | 2021-12-30 | 2025-12-02 | Cryosa, Inc. | Systems and methods for treatment of obstructive sleep apnea |
| US12564726B1 (en) | 2024-10-08 | 2026-03-03 | Btl Medical Solutions A.S. | Devices and methods for application of a magnetic field to the nervous system |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190005981A (ko) | 2019-01-16 |
| CN109310516A (zh) | 2019-02-05 |
| EP3454800A1 (en) | 2019-03-20 |
| JP2019514616A (ja) | 2019-06-06 |
| WO2017196548A1 (en) | 2017-11-16 |
| AU2017264512A1 (en) | 2018-11-22 |
| BR112018073275A2 (pt) | 2020-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250143919A1 (en) | Skin freezing systems for treating acne and skin conditions | |
| US20250120888A1 (en) | Liposomes, emulsions, and methods for cryotherapy | |
| US10555831B2 (en) | Hydrogel substances and methods of cryotherapy | |
| US20170326346A1 (en) | Permeation enhancers and methods of cryotherapy | |
| EP3454800A1 (en) | Skin freezing systems for treating acne and skin conditions | |
| US20250000562A1 (en) | Treatment systems and methods for affecting glands and other targeted structures | |
| EP3104796B1 (en) | Method and apparatus for affecting pigmentation of tissue | |
| EP3364900A1 (en) | Vascular treatment systems, cooling devices, and methods for cooling vascular structures | |
| US20200069458A1 (en) | Compositions, treatment systems, and methods for fractionally freezing tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20230725 |